This report by PHG Foundation for NHS England, The personalised medicine technology landscape presents an independent evidence synthesis to inform the NHS as it continues to develop its approaches and policies to support the delivery of increasingly personalised medicine, through the implementation of advanced medical technologies.
The report looks at the healthcare applications of a range of genomic and ‘omics technologies, from pharmacogenomics to liquid biopsy and transcriptomics – and goes further, to evaluate the prospects for a host of other technologies with the potential to personalise healthcare, from advanced image analysis and wearables to 3D printing and regenerative medicine.
This evidence synthesis by the respected policy analysts at the PHG Foundation provides important insights as to how to take this vision forward and the issues we will face in implementation.
Professor Dame Sue Hill, Chief Scientific Officer and SRO for Genomics, NHS England
Informed by a process of extensive research and analysis and produced in consultation with relevant experts and stakeholders this report:
- Reviews the biomedical and digital technologies that could contribute to the personalisation of medicine
- Identifies and describes examples of technologies that could be used to underpin the delivery of personalised medicine within the next three years
- Analyses how such approaches could be integrated most effectively within the NHS
- Highlights key considerations for NHS England to develop and deliver personalised medicine
You can read the executive summary here
The full report, The personalised medicine technology landscape, is available to read free online or to download here (PDF)
By Sobia Raza, Laura Blackburn, Sowmiya Moorthie, Sarah Cook, Emma Johnson, Louise Gaynor and Mark Kroese
